Details of Hydraulic Jumps for Design Criteria of Hydraulic Structures

The pharmaceutical industry has undergone a severe economic crunch in antibiotic discovery research due to evolving bacterial resistance along with enormous time and money that gets consumed in de novo drug design and discovery strategies.Nevertheless, drug repurposing has evolved as an economically safer and excellent alternative strategy to identify approved drugs for new therapeutic indications.Virtual high throughput screening (vHTS) and phenotype-based high throughput screening (HTS) of approved molecules play a crucial role in identifying, developing, and repurposing old drug molecules into anti-infective agents either alone or in synergistic combination with antibiotic therapy.This chapter briefly explains the process of drug repurposing/repositioning in comparison to de novo methods utilizing vHTS and HTS technologies along with 'omics-and poly-pharmacology-based drug repurposing strategies in the identification and development of anti-microbial agents.This chapter also gives an insightful survey of the intellectual property landscape on drug repurposing.Further, the challenges and applications of drug repurposing strategies in the discovery of anti-infective drugs are exemplified.The future perspectives of drug repurposing in the context of anti-infective agents are also discussed.